+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Therapeutics Market - Global Forecast 2026-2032- Product Image
Microbiome Therapeutics Market - Global Forecast 2026-2032- Product Image
New

Microbiome Therapeutics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674221
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The microbiome therapeutics market is experiencing substantial transformation, propelled by cutting-edge developments in microbial science, regulatory reforms, and strategic shifts in product development and commercialization. This combination of scientific and operational innovation is redefining industry standards and opening opportunities for senior executives to rethink competitive positioning.

Market Snapshot: Microbiome Therapeutics Market

The Microbiome Therapeutics Market expanded from USD 1.27 billion in 2025 to USD 1.45 billion in 2026, reflecting rising adoption of novel microbial-based interventions and therapeutic approaches. This sector is poised for strong continued growth at a compound annual growth rate (CAGR) of 15.22%, with forecasts pointing toward a value of USD 3.43 billion by 2032. Contributing factors include sustained investment in R&D, an expanding pipeline of live-biotherapeutic products, and increasing recognition of the clinical value underpinning microbiome modulation across multiple disease categories. Businesses are actively monitoring shifting regulatory requirements, seeking early alignment to expedite both clinical trials and market access. The landscape is marked by heightened competition, as biopharmaceutical players and new entrants position themselves to address unmet clinical needs through innovative therapies.

Scope & Segmentation

  • Product Types: Encompasses fecal microbiota transplantation, live-biotherapeutics, microbiome drugs, microbiome ecosystem therapies, probiotics, and prebiotics. Each product type warrants distinct development protocols, regulatory scrutiny, and market access strategies.
  • Therapeutic Areas: Addresses applications in autoimmune diseases, oncology, gastrointestinal disorders, infectious diseases, metabolic diseases, and neurological disorders, demonstrating broad clinical utility and differentiating market potential.
  • Formulation Routes: Oral, topical, and other targeted delivery methods; each route introduces specific considerations related to product stability, patient compliance, and regulatory review.
  • Sources: Sourcing spans animal, human, and environmental microbiomes, requiring tailored characterization and oversight to satisfy both safety and efficacy benchmarks.
  • End-Use Sectors: Includes academic research institutions, hospitals, and clinical settings, each with varying procurement processes, funding mechanisms, and requirements for data validation and reporting.
  • Distribution Channels: Offline and online pharmacies are utilized, encompassing hospital pharmacies as well as specialty and retail outlets for broader patient access.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific—all essential to capture regional variations in regulation, manufacturing infrastructure, and go-to-market dynamics.
  • Technology Focus: Advancements in engineered live-biotherapeutics, integration of multi-omics analytics, and the adoption of scalable, compliant bioprocessing technologies characterize modern development and production pipelines.

Key Takeaways: Strategic Insights for Senior Leaders

  • Scientific progress is moving beyond conventional probiotics, driving the creation of engineered live-biotherapeutics and multi-strain ecosystem therapies; these broaden therapeutic scope and signal the evolution of clinical care pathways.
  • Integrated regulatory strategy, robust manufacturing design, and consistent quality management are vital for minimizing time to market and ensuring clinical claims are substantiated.
  • Payer adoption and commercialization are increasingly shaped by a need for robust clinical evidence, such as biomarker deployment and real-world outcomes tracking, driving up standards for trial design and post-marketing surveillance.
  • Stakeholders from R&D to supply chain management must address operational challenges unique to their modality and indication, with a focus on scalability, distribution logistics, and partnership opportunities.
  • Collaboration, sector consolidation within contract development and manufacturing organizations, and active investment contribute to innovation acceleration and operational scaling, particularly for live microbial modalities.

Tariff Impact: U.S. 2025 Adjustments

Recent policy changes to U.S. tariffs in 2025 are altering cost structures and supply chain strategies for microbiome therapeutics manufacturers. Increased tariffs on imported raw materials, specialized laboratory reagents, and finished biologics have prompted organizations to adjust supplier contracts and consider nearshoring or localization of production to safeguard margins and ensure supply continuity. These shifts affect site selection, international clinical collaborations, and landed product costs, ultimately requiring proactive supply chain mapping and flexible sourcing models. Strategic planning is essential for mitigating operational risk and maintaining reliable commercial and clinical programs in this evolving environment.

Methodology & Data Sources

This analysis leverages primary insights from direct stakeholder interviews and is supplemented with peer-reviewed research, regulatory documents, and clinical trial data. Thematic synthesis, scenario analysis, and cross-validation with regulatory precedents support robust, transparent findings, while data quality is maintained through expert review and detailed documentation of any limitations.

Why This Report Matters

  • Advises senior management on aligning product and commercialization strategies with fluid regulatory and operational contexts to sustain competitive advantage.
  • Enables supply chain and manufacturing executives to anticipate and counteract policy-driven disruptions, particularly those arising from tariff changes or shifting raw material supply.
  • Empowers commercial and clinical teams to adapt market entry, reimbursement, and engagement plans to address regional nuances and payer expectations.

Conclusion

Achieving success in the microbiome therapeutics industry relies on the integration of research innovation, regulatory foresight, manufacturing strength, and commercial adaptability. Organizations that prioritize operational flexibility and demonstrate clear clinical impact are well-positioned for sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Microbiome Therapeutics Market, by Products
8.1. Fecal Microbiota Transplantation
8.2. Live-Biotherapeutics
8.3. Microbiome Drugs
8.4. Microbiome Ecosystem Therapies
8.5. Probiotics & Prebiotics
9. Microbiome Therapeutics Market, by Therapeutic Area
9.1. Autoimmune Diseases
9.2. Cancer
9.3. Gastrointestinal Disorders
9.4. Infectious Diseases
9.5. Metabolic Disorders
9.6. Neurological Disorders
10. Microbiome Therapeutics Market, by Formulation
10.1. Oral
10.2. Topical
11. Microbiome Therapeutics Market, by Source
11.1. Animal Microbiome
11.2. Environmental Microbiome
11.3. Human Microbiome
12. Microbiome Therapeutics Market, by End-use
12.1. Academic & Research Institutions
12.2. Hospitals & Clinics
13. Microbiome Therapeutics Market, by Distribution Channel
13.1. Offline
13.1.1. Hospital Pharmacies
13.1.2. Retail Pharmacies
13.2. Online Pharmacies
14. Microbiome Therapeutics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Microbiome Therapeutics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Microbiome Therapeutics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Microbiome Therapeutics Market
18. China Microbiome Therapeutics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Alveolus Bio, Inc. by ResBiotic
19.6. AOBiome LLC
19.7. Assembly Biosciences, Inc.
19.8. Axial Therapeutics, Inc.
19.9. BioGaia AB
19.10. BiomeBank
19.11. EnteroBiotix Ltd
19.12. Enterome SA
19.13. Ferring B.V.
19.14. Intralytix, Inc.
19.15. Kanvas Biosciences
19.16. Locus Biosciences, Inc.
19.17. MaaT Pharma SA
19.18. Microba Life Sciences Limited
19.19. Microbiotica Ltd.
19.20. MRM Health NV
19.21. NuBiyota
19.22. Osel, Inc.
19.23. Pendulum Therapeutics
19.24. PharmaBiome AG
19.25. Pylum Biosciences
19.26. Seres Therapeutics, Inc.
19.27. Servatus Limited
19.28. Siolta Therapeutics
19.29. Theriva Biologics, Inc.
19.30. Vedanta Biosciences, Inc.
19.31. Viome Life Sciences, Inc. by BlueDot LLC
19.32. Xbiome Co. Ltd.
List of Figures
FIGURE 1. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MICROBIOME THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY LIVE-BIOTHERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY LIVE-BIOTHERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY LIVE-BIOTHERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME ECOSYSTEM THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME ECOSYSTEM THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY MICROBIOME ECOSYSTEM THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ANIMAL MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ANIMAL MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ANIMAL MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ENVIRONMENTAL MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ENVIRONMENTAL MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ENVIRONMENTAL MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HUMAN MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HUMAN MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HUMAN MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 111. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 126. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 127. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 129. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. AFRICA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 143. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 144. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 145. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 147. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASEAN MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 149. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 151. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 152. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 153. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 154. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 155. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. GCC MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 165. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 167. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 168. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 169. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 170. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 171. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. BRICS MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 173. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 175. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 176. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 177. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 178. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 179. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. G7 MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 181. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 183. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 184. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 185. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 186. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 187. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. NATO MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL MICROBIOME THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 198. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 200. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 201. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 202. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 203. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
TABLE 204. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. CHINA MICROBIOME THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Microbiome Therapeutics market report include:
  • Alveolus Bio, Inc. by ResBiotic
  • AOBiome LLC
  • Assembly Biosciences, Inc.
  • Axial Therapeutics, Inc.
  • BioGaia AB
  • BiomeBank
  • EnteroBiotix Ltd
  • Enterome SA
  • Ferring B.V.
  • Intralytix, Inc.
  • Kanvas Biosciences
  • Locus Biosciences, Inc.
  • MaaT Pharma SA
  • Microba Life Sciences Limited
  • Microbiotica Ltd.
  • MRM Health NV
  • NuBiyota
  • Osel, Inc.
  • Pendulum Therapeutics
  • PharmaBiome AG
  • Pylum Biosciences
  • Seres Therapeutics, Inc.
  • Servatus Limited
  • Siolta Therapeutics
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc. by BlueDot LLC
  • Xbiome Co. Ltd.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.45 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.43 Billion
Compound Annual Growth Rate15.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Human Microbiome Market - Global Forecast 2026-2032 - Product Image

Human Microbiome Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Microbiome Diagnostics Market - Global Forecast 2026-2032 - Product Image

Microbiome Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Microbiome Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers - Product Image

Microbiome Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers

  • Report
  • 397 Pages
  • Global
From
Human Microbiome Market Industry Trends and Global Forecasts to 2035, by Type of Product, Type of Molecule, Target Indication, Therapeutic Area, Route of Administration and Key Geographical Regions - Product Image

Human Microbiome Market Industry Trends and Global Forecasts to 2035, by Type of Product, Type of Molecule, Target Indication, Therapeutic Area, Route of Administration and Key Geographical Regions

  • Report
  • 552 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030 - Product Image

Live Biotherapeutic Products and Microbiome CDMO Market Size, Share & Trends Analysis Report by Application (C. Difficile, Crohn's Disease, IBS, Diabetes), Region (North America, Europe, APAC, MEA) with Growth Forecasts, 2025-2030

  • Report
  • 137 Pages
  • Global
From

About the Microbiome Market

The Microbiome market is a subset of the biotechnology industry that focuses on the study of microbial communities and their interactions with the environment. It is a rapidly growing field, with research and development activities focusing on the development of new products and services that can be used to improve human health and the environment. Microbiome-based products and services are used in a variety of industries, including pharmaceuticals, food and beverage, agriculture, and cosmetics. The Microbiome market is driven by the increasing demand for personalized medicine, as well as the need for more efficient and cost-effective treatments for various diseases. Additionally, the development of new technologies, such as next-generation sequencing and metagenomics, has enabled researchers to better understand the composition and function of microbial communities. Companies in the Microbiome market include Second Genome, uBiome, Seres Therapeutics, and Enterome Bioscience. These companies are focused on developing products and services that can be used to improve human health and the environment. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.